| Gender | Age group | Mode of treatment | Outlet type | ||||||
---|---|---|---|---|---|---|---|---|---|---|
 | Male | Female | <5 years | 5-12 years | ≥13 years | Self-treatment | Outlet treatment | Prescription | Pharmacy | PMV |
n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |
Drug category | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
ACT | 527 (71.4) | 434 (74.3) | 74 (87.1) | 102 (91.9) | 785 (70.0) | 318 (52.2) | 425 (90.) | 218 (90.8) | 594 (74.1) | 367 (70.7) |
Monotherapy | 211 (28.6) | 149 (25.6) | 11 (12.9) | 9 (8.1) | 340 (30) | 291 (48.8) | 47 (10.0) | 22 (9.2) | 208 (25.9) | 152 (29.5) |
Total | 738 | 583 | 85 | 111 | 1125 | 609 | 472 | 240 | 802 | 519 |
Treatment mode | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Prescription | 132 (17.9) | 108 (18.5) | 34 (40.0) | 25 (22.5) | 181 (16.1) | - | - | - | 138 (17.2) | 102 (19.6) |
Recommendation | 263 (35.6) | 209 (35.9) | 31 (36.5) | 44 (39.6) | 397 (35.3) | - | - | - | 262 (32.7) | 210 (40.5) |
Self-treatment | 343 (46.5) | 266 (45.6) | 20 (23.5) | 42 (37.9) | 547 (48.6) | - | - | - | 402 (50.1) | 207 (39.9) |
Total | 738 | 583 | 85 | 111 | 1125 | Â | Â | Â | 802 | 519 |
AMFm | 170 (32.2) | 156 (36.0) | 30 (40.5) | 54 (53) | 242 (31) | 100 (32) | 165 (39) | 61 (28) | 164 (27.6) | 162 (44) |